entity

SON

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SON: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
30Hypotheses
4Analyses
1Outgoing
2Incoming
6Experiments
4Debates

No AI portrait yet

Wiki Pages (4)

Knowledge base pages for this entity

Canonical Page

Supraoptic Nucleus Expanded v2

cell · 1064 words

Supraoptic Nucleus (SON) Neurons

cell · 670 words

PARKINSON

entity · 667 words

Supraoptic Nucleus (SON) Neurons

cell · 646 words

Outgoing (1)

TargetRelationTypeStr
ds-83b31ef18d49provides_data_fordataset1.00

Incoming (2)

SourceRelationTypeStr
ds-83b31ef18d49data_indataset1.00
VASOPRESSINexpressed_inprotein0.68

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
LRRK2 G2019S Kinase Inhibition for Parkinson's Disease 0.795 neurodegeneration Test
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
GBA1/GCase restoration to reduce alpha-synuclein pathology i 0.760 neurodegeneration Test
LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein 0.745 neurodegeneration Test
NLRP3 Inflammasome Inhibition for Neuroprotection in Parkins 0.720 neurodegeneration Test
Pharmacologic activation of GBA1 to reduce alpha-synuclein b 0.720 neurodegeneration Test
Magnetosonic-Triggered Transferrin Receptor Clustering 0.719 neurodegeneration Blood-brain barrier transport mechanisms
LRRK2 kinase inhibition to normalize lysosomal trafficking i 0.710 neurodegeneration Test
Dasatinib plus Quercetin Senolytic Clearance of p16Ink4a-Hig 0.680 neurodegeneration -
Mitophagy and NAD pathway enhancement in sporadic Parkinson' 0.670 neurodegeneration Test
Alpha-synuclein phosphorylation-dominated LLPS hijacks synap 0.657 parkinsons -
LRRK2 Haploinsufficiency Traps Microglia in Senescence-Like 0.650 parkinsons -
Chronic ISR Activation Represses Axonal Protein Synthesis in 0.650 parkinsons -
HCN1-Mediated Resonance Frequency Stabilization Therapy 0.648 neurodegeneration Selective vulnerability of entorhinal co
PINK1/Parkin-pathway mitophagy impairment in sporadic Parkin 0.630 neurodegeneration Test
APOE4-Targeted Ultrasonic Lipidation Enhancement for Gamma O 0.625 alzheimers -
SUV39H1 Restoration Represses Aberrant Transposon Expression 0.620 neurodegeneration Investigate mechanisms of epigenetic rep
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia 0.610 neuroinflammation How do regional, age, and sex-dependent
whether debate-structured causal reasoning improves calibrat 0.604 neurodegeneration Causal Discovery Benchmark: SciDEX vs LL
Exosomal α-Synuclein as an Interneuronal Propagation Vector 0.595 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
Mitophagy Induction as Neuroprotective Strategy in Sporadic 0.585 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
Selectively Inhibit Maladaptive AQP4-Driven Astrocyte-Microg 0.500 neurodegeneration How can AQP4 be effectively targeted the
Sonic hedgehog pathway compartmentalization as quantitative 0.485 neuroscience How can subcellular compartmentalization
USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's 0.393 neurodegeneration Test
TFEB Activation to Restore Lysosomal Function in Parkinson's 0.380 proteomics Quantitative proteomics of the aging syn
TFEB Activation to Restore Lysosomal Biogenesis in Parkinson 0.380 proteomics Quantitative proteomics of the aging syn
Individual Baseline Variability in p-tau217 Half-Life Dictat 0.335 - Can CSF p-tau217 normalization serve as
Multi-Clock Ensemble Discordance as a Parkinson's Disease Pr 0.323 - Epigenetic clocks as biomarkers for Alzh
Stress-Activated Retrotransposon Epigenetic Regulation (SARE 0.000 - Do different priming stimuli require dis
Personalized DBS Programming Based on GBA Genotype-Specific 0.000 - GBA-Synuclein Loop: Therapeutic Strategi

Mentioning Analyses (4)

Scientific analyses that reference this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-28 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Experiments (6)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
iPSC-derived endothelial cell iron uptake with RLS CSF exposure exploratory restless legs syndrome 0.900 0.00 iPSC-derived human endothelial proposed N/A
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin falsification Neuroinflammation 0.400 0.50 mouse proposed $200,000
s:** - Compare uptake with/without magnetic particles using tight junc falsification Neurodegeneration 0.400 0.50 cell_line proposed $120,000
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000
AAV Serotype Comparison for LRRK2 Knockdown in PD validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] Sehlin D, Hultqvist G, Michno W, Aguilar J Prev Alzheimers Dis 2025 1
Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z Exp Neurol 2023 1
On Iron Metabolism and Its Regulation. [PMID:33925597] Vogt AS, Arsiwala T, Mohsen M, Vogel M, Int J Mol Sci 2021 1
Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] Feng H, Schorpp K, Jin J, Yozwiak CE, Ho Cell Rep 2020 1
Transferrin and transferrin receptors update. [PMID:29969719] Kawabata H Free Radic Biol Med 2019 1
Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] Lu Y, Zhang Y, Niu C Comp Biochem Physiol A Mol Int 2026 0
Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam J Trace Elem Med Biol 2026 0
Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] Piotrowsky A, Leischner C, Schmieder H, Oncol Rep 2026 0
Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng American journal of translatio 2026 0
Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] Zemmouche M, Falque G, Cadet F, Gardebie Journal of molecular graphics 2026 0
[Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] Wang YF, Dong YS Zhen ci yan jiu = Acupuncture 2026 0
The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H Apoptosis : an international j 2026 0
The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] Osmanlioglu Dag SR, Tatli Cankaya II, Oz Anti-cancer agents in medicina 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Raccoon eyes [PMID:35789012] Ning Junjie Journal of Paediatrics and Chi 2023 0
The Trend of Immunotherapy Combined with Nanomedicine. [PMID:34789123] Shigao Huang; Qi Zhao Current medicinal chemistry 2022 0
Test-retest reliability for performance-based outcome measures among individuals [PMID:35123456] ["Sions J", "Donohoe M", "Beisheim-Ryan BMC musculoskeletal disorders 2022 0
Interfacial Imide Polymerization of Functionalized Filled Microcapsule Templates [PMID:36234567] ["Wei Z", "Ma X", "Wang P", "Pan J"] Nanomaterials (Basel, Switzerl 2022 0
The impact of COVID-19 and non-pharmaceutical interventions on energy returns wo [PMID:36567890] ["Saif-Alyousfi A", "Saha A"] Sustainable cities and society 2021 0

Debates (4)

Multi-agent debates referencing this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

Related Research

Hypotheses and analyses mentioning SON in their description or question text

Pharmacologic activation of GBA1 to reduce alpha-synuclein burden in Parkinson's

Score: 0.720 · neurodegeneration · 2026-05-01

GBA1 mutations represent the strongest genetic risk factor for PD (OR 5-20x), and GCase dysfunction creates a druggable

Magnetosonic-Triggered Transferrin Receptor Clustering

Score: 0.719 · neurodegeneration · 2026-04-02

## Mechanistic Overview Magnetosonic-Triggered Transferrin Receptor Clustering starts from the claim that modulating TFR

LRRK2 kinase inhibition to normalize lysosomal trafficking in Parkinson's diseas

Score: 0.710 · neurodegeneration · 2026-05-01

LRRK2 G2019S mutations cause autosomal dominant PD through hyperactivation that impairs vesicular trafficking via Rab GT

Mitophagy and NAD pathway enhancement in sporadic Parkinson's disease

Score: 0.670 · neurodegeneration · 2026-04-29

Sporadic Parkinson's disease may involve impaired mitochondrial quality control, and NAD augmentation or other mitophagy

HCN1-Mediated Resonance Frequency Stabilization Therapy

Score: 0.648 · neurodegeneration · 2026-04-02

## Mechanistic Overview HCN1-Mediated Resonance Frequency Stabilization Therapy starts from the claim that modulating HC

PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease

Score: 0.630 · neurodegeneration · 2026-04-30

Sporadic PD may include impaired mitochondrial quality control, reduced mitophagy flux, and dopaminergic vulnerability o

SUV39H1 Restoration Represses Aberrant Transposon Expression in Aging Neurons

Score: 0.620 · neurodegeneration · 2026-04-21

## **Molecular Mechanism and Rationale** SUV39H1 (Suppressor of Variegation 3-9 Homolog 1), also known as KMT1A (lysine

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Score: 0.610 · neuroinflammation · 2026-04-22

## Mechanistic Overview Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Disease Pathology s

whether debate-structured causal reasoning improves calibration over direct LLM

Score: 0.604 · neurodegeneration · 2026-04-28

The debate supports carrying forward whether debate-structured causal reasoning improves calibration over direct LLM bas

Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disea

Score: 0.595 · neurodegeneration · 2026-04-26

Misfolded α-synuclein aggregates are transmitted via exosomes from donor to recipient neurons, templating endogenous aSy